Bank Mandiri Persero Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank Mandiri Persero Tbk trades at Rp4,310 (market cap 388.08T, 103.03M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.42M 24h volume). The key difference: Bank Mandiri Persero Tbk is far larger — about 672.9× UBC Medical Indonesia Tbk.'s market cap, and Bank Mandiri Persero Tbk is more actively traded (103.03M versus 3.42M). Which is the better fit depends on your goals.
| BMRI | LABS | |
|---|---|---|
Market Cap | 388.08T | 576.7B |
Volume | 103.03M | 3.42M |
Lot | 1.03M | 34.23K |
Turnover | 440.56B | 513.94M |
Average Price | 4,275.93 | 150.16 |
Value | 440.56B | 513.94M |
Indicative Equilibrium Price | 4,310 | 148 |
Indicative Equilibrium Volume | 172.5K | 350 |
Trailing returns across standard periods
Latest headlines on both assets
Bank Mandiri was established at 2 Oct 1998 and start in commercial activity at 1 Aug 1999. As a result of merge 4 banks (Bank Bumi Daya, Bank Dagang Negara, Bank Exim and Bapindo), Bank Mandiri is Indonesia's largest national bank (assets) as per Dec 31, 2002. Bank Mandiri main activities are corporate banking, commercial banking and consumer banking.
Read more on BMRI →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →